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Abstract
Background: Following the September 11, 2001, attacks on the World Trade Center (WTC), thousands of workers were
exposed to an array of toxins known to cause adverse health effects, including cancer. This study evaluates cancer incidence
in the WTC Health Program General Responder Cohort occurring within 12 years post exposure.
Methods: The study population consisted of 28 729 members of the General Responder Cohort enrolled from cohort
inception, July 2002 to December 31, 2013. Standardized incidence ratios (SIRs) were calculated with cancer case inclusion
and follow-up starting post September 11, 2001 (unrestricted) and, alternatively, to account for selection bias, with case inclusion and follow-up starting 6 months after enrollment in the WTC Health Program (restricted). Case ascertainment was based
on linkage with six state cancer registries. Under the restricted criterion, hazard ratios were estimated using multivariable
Cox proportional hazards models for all cancer sites combined and for prostate cancer.
Results: Restricted analyses identified 1072 cancers in 999 responders, with elevations in cancer incidence for all cancer sites
combined (SIR ¼ 1.09, 95% confidence interval [CI] ¼ 1.02 to 1.16), prostate cancer (SIR ¼ 1.25, 95% CI ¼ 1.11 to 1.40), thyroid
cancer (SIR ¼ 2.19, 95% CI ¼ 1.71 to 2.75), and leukemia (SIR ¼ 1.41, 95% CI ¼ 1.01 to 1.92). Cancer incidence was not associated
with any WTC exposure index (composite or individual) for all cancer sites combined or for prostate cancer.
Conclusion: Our analyses show statistically significant elevations in cancer incidence for all cancer sites combined and for
prostate and thyroid cancers and leukemia. Multivariable analyses show no association with magnitude or type of exposure.

Following the attacks on the World Trade Center (WTC) towers
on September 11, 2001, more than 50 000 workers (1) were involved in rescue and recovery, with many of them caught directly in the dust cloud from the collapsing towers. The
potential exposure of these workers extended until cleanup of
the site ended in June 2002. The complex, sustained exposure
and the unknown long-term health effects it may cause are
matters of national concern and the subject of continued monitoring and research. Because of the presence of carcinogens (asbestos, polychlorinated biphenyls, benzene, dioxins) (2), several

studies have examined cancer incidence among different WTCexposed responder cohorts compared with the general population. A 10-year post–September 11 study by the WTC Health
Registry of recovery workers and of people exposed in the vicinity of the WTC found a statistically significant greater incidence
in all reportable, cancer registry types combined, with a standardized incidence ratio (SIR) of 1.11 (3). A study of 7-year post–
September 11 cancer incidence among members of the WTC
Health Program General Responder Cohort (eg, law enforcement, construction, telecommunication workers) found a 15%
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elevation in all-site cancer incidence (4,5). A study of New York
City Fire Department (FDNY) firefighters found a slight, yet statistically significant, incidence elevation in all sites combined
(6). However, a later study comparing the same cohort with
other firefighters with similar occupational (but not WTC)
exposures found no greater all-sites-combined incidence (7).
This article is an update of the earlier Solan et al. study (4) of
the General Responder Cohort extending follow-up time by an
additional 5 years, thereby increasing sample size and, given
the longer latency for some cancers, the ability to detect associations between WTC exposure and cancer risk. Solan et al. used
an unrestricted criterion, where cancer counts and personyears of observations began post September 11, and a restricted
criterion, where both counts and person-years began 6 months
after member enrollment in the WTC Health Program. When
using the restricted approach, the earlier study found elevations
in thyroid cancer only.
Cancer is now classified as a WTC-related condition by the
National Institute for Occupational Safety and Health, and diagnosed members of the WTC Health Program are eligible for federally funded treatment. The General Responder Cohort is an
open cohort, with new members enrolling as of the end date of
this study (year 2013). Members have many reasons to enroll,
including having a cancer certified for federally funded treatment. To reduce bias from sicker members disproportionately
self-selecting into the program, we focused on the restricted criterion, excluding cancer cases and person-years of observation
before the date of member enrollment plus 6 months. (For comparison with Solan et al. [before cancer was designated as WTC
related], unrestricted criterion results are included as
Supplementary Material, available online).

Methods
The WTC Health Program General Responder Cohort has been
described in detail elsewhere (8). Briefly, the WTC Health
Program is a federally funded medical monitoring and treatment program designed to assess responder health over time
and to provide treatment for health conditions deemed WTC
related. Human investigations are performed after approval by
local institutional review boards and in accord with assurances
filed with and approved by the US Department of Health and
Human Services.
The study population included all members enrolled in the
WTC Health Program General Responder Cohort between its inception (July 2002) and the end of follow-up (December 31, 2013,
for New York residents and December 31, 2012, for residents of
other states). To be included in these analyses, the following eligibility requirements pertained: self-reported time working on
the WTC rescue and recovery effort was a 4-hour minimum in
the first 4 days from September 11, 2001, 24 hours in September
2001, or 80 hours in September–December 2001; consent to have
data aggregated for research; consent to have data shared with
cancer registries; and completion of at least one monitoring
visit (8).
Cancer cases were ascertained via linkage with the cancer
registries of New York (NY) and surrounding states of New
Jersey, Pennsylvania, and Connecticut, as well as Florida and
North Carolina, where responders are known to retire. Cohort
percentages living in these states at some point post
September 11 were 87.7% (NY), 8.9% (New Jersey), 1.3% (Florida),
1.2% (Pennsylvania), 0.6% (Connecticut), and 0.3% (North
Carolina). Linkages used probabilistic matching algorithms

based on name, address, social security number (SSN), sex, race,
and birth date. Registries use differing matching algorithms and
degrees of manual review; false positive and false negative
matches are possible, especially for those missing full SSN (full
SSN was available for 31.8% of the study population and the last
four SSN digits for an additional 15.1%). The NY registry performed an additional and extensive manual review of possible
matches using Department of Motor Vehicle records and other
sources.
The NY registry data are complete through December 31,
2013, and the others through December 31, 2012. Consequently,
person-years based on responders’ most recently reported state
of residence were censored to December 31, 2013, for NY residents and to December 31, 2012, for residents of the five other
states; residents of all other states were excluded from the analysis. Overlapping reporting of cancer among state registries was
assessed via manual review; duplicates were removed to yield a
dataset of unique registry-reported cancer cases for analysis.
Cancer cases were grouped into an “all cancer sites
combined” category and into individual groupings per the
National Cancer Institute’s Surveillance, Epidemiology, and End
Results site recode classifications (https://seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html).
WTC exposure indices were obtained via a structured exposure assessment interview and consisted of reported exposure
to the dust cloud (direct, significant, some, none) combined
with arrival time (first day on the effort between September 11
and September 14 inclusive, first day on the effort after
September 14); cumulative days working on the WTC effort; and
working directly on the debris pile at any time.
A four-level (low, medium, high, very high) composite of
these exposure measures was also used (9) and defined as follows: Low- and medium-exposure groups consisted of those
who were not directly in the dust cloud, with the low-exposure
group also requiring fewer than 40 days working on the WTC effort and not having worked at any time on the debris pile. The
high and very high groups consisted of those who were directly
in the dust cloud, with the very high group also requiring 90 or
more days working on the WTC effort and working at some
point on the debris pile.
This study includes exposure assessment and demographic
data from monitoring visits starting 2002 through December 31,
2013. The exposure assessment questionnaire was administered at members’ initial monitoring visits only. Demographic
information, smoking status, and member address were
obtained at first visit and updated at subsequent monitoring
visits; address information was also updated through outreach
efforts by the WTC Health Program and by member communications with the program’s phone bank. The average number of
member visits was 4.3, and average time between visits was
1.9 years.

Statistical Analysis
To calculate SIRs, population rates were extracted using
SEER*STAT software, and expected counts were derived through
indirect standardization to the age, sex, race and/or ethnicity,
diagnosis year, and residency-state-specific population rates.
These calculations were performed for each year of observation
and then summed so that members could be aged yearly.
Residence state from a member’s most recent monitoring visit
was used for combining with external rates. Observed counts
were extracted from our registry-confirmed cancer dataset.
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Under the restricted criterion, person-years of observation and
observed counts began 6 months after member enrollment
through December 31, 2013, for NY residents and December 31,
2012, for everyone else. Based on a linkage with the National
Death Index, deceased members were censored at date of death.
Both external population rates and our observed counts can include multiple cancer primaries per person (ie, a member with
two stomach cancer primaries and colon cancer would be
counted twice in the calculation of the site-specific SIR for
stomach cancer and once for colon cancer). The 95% confidence
intervals (CIs) for the SIRs (not presented by sex because of
small numbers) were calculated using standard methods (10).
For comparison with previous research (4), unrestricted SIRs
were calculated by not limiting to 6 months’ post enrollment (ie,
follow-up time and cancer cases started September 11, 2001). To
test the adequacy of the restricted criterion’s 6-month threshold
to fully account for bias from selective enrollment due to
prediagnosis symptoms of cancer, SIRs were calculated as a
sensitivity analysis, with follow-up time and case inclusion beginning 12 and 24 months postenrollment.
To address potential confounders and explore the effects of
WTC exposure and demographic variables on cancer risk, hazard
ratios (HR) and 95% CIs were estimated using multivariable Cox
proportional hazards models. Estimations were calculated separately for all cancer sites combined and for prostate cancer, with
censoring at date of death, end-of-study, or cancer diagnosis
date. No violations of the proportional hazards assumption were
observed when tested using Schoenfeld residuals. We modeled
multiple cancer events per member by using a shared frailty
model, with subject treated as a gamma-distributed random effect to account for within-subject correlations among cancer
event times (11). The time scale for the model was calendar time
from September 11, 2001, but entry into the model was lefttruncated at 6 months’ postenrollment, per our restricted criterion. In addition to the four-level exposure metric, the model included race and/or ethnicity, WTC Health Program clinic, sex,
age on September 11, 2001 smoking status, pre–September 11 occupation, presence of SSN for registry matching, and enrollment
date. These known and suspected cancer risk factors are consistent with Solan et al. (4) and control for the heterogeneous nature of the types of responders in our cohort. A separate model,
using the same covariates but substituting the three primary exposure indices for the four-level derived indices, was also examined. All models used the restricted criterion.

Results
Demographics
Of the 29 455 responders with appropriate consents and whose
information was provided to the cancer registries for linkage,
726 were excluded because their restricted criterion start date
(enrollment date þ 6 months) occurred after the end date of
available registry data or after their date of death, leaving an
analysis sample size of 28 729.
The 28 729 responders were predominantly male (85.5%),
white non-Hispanic (47.4%) with a median age of 38 years on
September 11, 2001 (Table 1). Construction and protective services (eg, law enforcement) were the most common pre–
September 11 occupations (20.8% and 49.0%, respectively), and
44.4% had at least some level of exposure to the dust cloud
caused by the collapse of the WTC towers. The median time
spent working on the rescue and recovery effort was 52 days.

Table 1. Selected characteristics of the World Trade Center Health
Program General Responder study sample (N ¼ 28 729)*
Characteristic
Sex
Male
Female
Median age on 9/11/2001, y
Race/ethnicity
Black
White non-Hispanic
White Hispanic
Hispanic (missing race)
Other race
Unknown/missing
Occupation
Protective services
Construction
CM&IRG
Other
Smoking history
Current
Former
Never
Missing
Clinical center at time of first visit
Bellevue
Mount Sinai Hospital
Queens
Stony Brook
Rutgers
Derived exposure level
Very high
High
Intermediate
Low
Missing
Dust exposure/arrival time
Direct dust exposure
Significant dust exposure
Some dust exposure
No exposure/arrival 9/11–9/14
No exposure/arrival after 9/14
Missing
Duration on effort, d
1st quartile, 1–17
2nd quartile, 18–52
3rd quartile, 53–114
4th quartile, >114
Missing
Worked on pile/pit
Yes
No
Missing
SSN full or partial sent to registry
Yes
No
Date of enrollment
2002–2005
2006–2009
2010–2013

No. (%)

24 568 (85.52)
4161 (14.48)
38
3068 (10.68)
13 620 (47.41)
534 (1.86)
4622 (16.09)
1938 (6.75)
4947 (17.22)
14 087 (49.03)
5975 (20.80)
2636 (9.18)
6031 (20.99)
4290 (14.93)
7069 (24.61)
17 125 (59.61)
245 (0.85)
1313 (4.57)
19 503 (67.89)
2149 (7.48)
4561 (15.88)
1203 (4.19)
920 (3.20)
4896 (17.04)
17 479 (60.84)
4120 (14.34)
1314 (4.57)
5876 (20.45)
4822 (16.78)
2046 (7.12)
8480 (29.52)
6400 (22.28)
1105 (3.85)
7161 (24.93)
6788 (23.63)
7096 (24.70)
6987 (24.32)
697 (2.43)
10 188 (35.46)
17 636 (61.39)
905 (3.15)
13 462 (46.86)
15 267 (53.14)
14 141 (49.22)
10 513 (36.59)
4075 (14.18)

*CM&IRG ¼ buildings and grounds cleaning and maintenance and electrical,
telecommunications and other installation and repair groups; SSN ¼ social
security number.
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Table 2. Standardized incidence ratios (SIRs) of selected cancers among World Trade Center Health Program General Responders, 2003–2013*:
restricted criterion
Site
All cancer sites combined
Smoking-related†
Oral cavity and pharynx
Digestive system
Esophagus
Stomach
Colon and rectum
Liver and intrahepatic bile duct
Pancreas
Nose, nasal cavity, and middle ear
Larynx
Lung and bronchus
Soft tissue including heart
Melanoma of the skin
Breast
Corpus uteri
Prostate
Testis
Urinary bladder
Kidney and renal pelvis
Brain and other nervous system
Thyroid
Hematological
Hodgkin lymphoma
Non-Hodgkin lymphoma
Myeloma
Leukemia
CLL
AML
Mesothelioma

Observed

Expected

SIR (95% CI)

Median time 9/11/01 to cancer diagnosis, y

1072
300
34
163
19
19
68
24
18
<5
10
80
7
50
47
8
298
10
48
54
21
73
106
7
47
12
40
12
12
<5

984.4
304.9
35.3
180.2
13.0
17.8
84.0
25.2
23.0
—
12.0
96.2
7.9
43.3
50.3
9.8
238.7
14.5
44.2
46.7
15.6
33.4
100.6
8.4
48.8
15.0
28.4
11.1
7.6
—

1.09 (1.02 to 1.16)
0.98 (0.88 to 1.10)
0.96 (0.67 to 1.34)
0.90 (0.77 to 1.05)
1.46 (0.88 to 2.28)
1.07 (0.64 to 1.67)
0.81 (0.63 to 1.03)
0.95 (0.61 to 1.42)
0.78 (0.46 to 1.24)
1.14
0.83 (0.40 to 1.53)
0.83 (0.66 to 1.04)
0.88 (0.35 to 1.82)
1.15 (0.86 to 1.52)
0.94 (0.69 to 1.24)
0.82 (0.35 to 1.61)
1.25 (1.11 to 1.40)
0.69 (0.33 to 1.27)
1.09 (0.80 to 1.44)
1.16 (0.87 to 1.51)
1.34 (0.83 to 2.05)
2.19 (1.71 to 2.75)
1.05 (0.86 to 1.27)
0.83 (0.34 to 1.72)
0.96 (0.71 to 1.28)
0.80 (0.41 to 1.40)
1.41 (1.01 to 1.92)
1.08 (0.56 to 1.89)
1.58 (0.82 to 2.76)
1.25

8.6
8.9
8.3
8.6
8.2
8.3
7.8
9.2
9.7
8.5
9.8
9.2
5.2
8.6
8.8
9.6
8.6
5.9
9.3
9.2
8.6
8.7
8.4
6.5
8.5
8.3
8.5
8.7
8.0
6.5

*Begins 6 months past member enrollment, with enrollment beginning July 2002. AML ¼ acute myeloid leukemia; CI ¼ confidence interval; CLL ¼ chronic lymphocytic
leukemia.
†Smoking-related cancers consist of the following cancer types: oral cavity and pharynx (excluding nasopharynx), esophagus, liver, intrahepatic bile duct, pancreas, respiratory system (excluding pleura), urinary system, and acute myeloid leukemia.

SIR Results

12- and 24-Month Restricted Sensitivity Analyses

Restricted Analyses
1072 cancers were identified among 999 responders. All cancer
sites combined showed a statistically significant elevation in incidence (SIR ¼ 1.09, 95% CI ¼ 1.02 to 1.16) (Table 2), driven
mostly by elevations in incidences of prostate cancer (SIR ¼
1.25, 95% CI ¼ 1.11 to 1.40) and thyroid cancer (SIR ¼ 2.19, 95% CI
¼ 1.71 to 2.75). In contrast to Solan et al. (4), the incidence of leukemia was statistically significantly elevated (SIR ¼ 1.41, 95% CI
¼ 1.01 to 1.92). For esophageal and brain cancers, elevated incidence of 46% and 34%, respectively, were observed, but neither
achieved statistical significance. Lung cancer showed a decreased SIR (0.83, 95% CI ¼ 0.66 to 1.03) that was not statistically
significant, as did colorectal cancer (SIR ¼ 0.81, 95% CI ¼ .63 to
1.03).

Twelve- and 24-month sensitivity analyses were performed
(Supplementary Table 1, available online). As with the 6-month
restricted analysis, prostate cancer maintained statistically significant elevations in cancer incidence for both the 12-month
(SIR ¼ 1.23, 95% CI ¼ 1.09 to 1.38) and the 24-month (SIR ¼ 1.21,
95% CI ¼ 1.06 to 1.37) restricted criteria. Likewise, thyroid cancer
maintained a statistically significant elevation in cancer incidence for both the 12-month criterion (SIR ¼ 2.18, 95% CI ¼ 1.70
to 2.76) and the 24-month criterion (SIR ¼ 2.11, 95% CI ¼ 1.61 to
2.72). All cancer sites combined maintained a statistically significant elevation for the 12-month criterion (SIR ¼ 1.07, 95% CI ¼
1.01 to 1.14) and borderline statistical significance for the 24month criterion (SIR ¼ 1.06, 95% CI ¼ 0.99 to 1.13). The incidence
of leukemia was no longer elevated, although results were
based on diminishing numbers of cases.

Unrestricted Analyses

Multivariable Analysis

The unrestricted criterion yielded statistically significant elevations in SIRs for all cancer sites combined, and with melanoma
of the skin, prostate, bladder, kidney and thyroid cancers,
hematologic neoplasms, leukemia, non-Hodgkin lymphoma,
multiple myeloma, and chronic lymphocytic leukemia.

Exposure Indices
None of the three separate exposure measures (dust exposure
and arrival time, length of work time, or work on the pile) and
none of the levels of the derived, four-level WTC exposure index
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displayed a statistically significant association with cancer risk,
for both all cancer sites combined and prostate cancer (Table 3).

Table 3. Hazard ratios of select exposure and demographic factors:
multivariate Cox model of cancer risk for all cancer sites combined
(men and women) and prostate cancer (men only)*

Demographic and Other Variables
The multivariable analysis of all cancer sites combined (Table 3)
suggested an elevated risk for men, compared with women, but
the association did not achieve statistical significance (HR ¼
1.21, 95% CI ¼ 0.97 to 1.52). Age on September 11, 2001, showed a
statistically significant elevation of cancer risk, with a 1.09-fold
greater risk for each 1-year increase (HR ¼ 1.09, 95% CI ¼ 1.08 to
1.10), and being a current smoker likewise showed a statistically
significant association, with a 1.29-fold greater cancer risk compared with being a never smoker (HR ¼ 1.29, 95% CI ¼ 1.07 to
1.57). Being a former smoker was not associated with having an
elevated cancer risk compared with being a never smoker (HR ¼
1.0, 95% CI ¼ 0.85 to 1.17).
In the multivariable analysis of prostate cancer (Table 3), age
on September 11, 2001, was statistically significant and was associated with a 1.13-fold greater cancer risk for each 1-year increase (HR ¼ 1.13, 95% CI ¼ 1.12 to 1.14); current and former
smokers were associated with lower cancer risk compared with
never smokers (HR ¼ 0.74, 95% CI ¼ 0.50 to 1.10, and HR ¼ 0.94,
95% CI ¼ 0.73 to 1.21, respectively).

Supplemental Multivariable Results
To test the adequacy of a 6-month threshold to account for selection bias, 12- and 24-month multivariable sensitivity analyses were performed (Supplementary Table 2, available online).
Age on September 11, 2001, and current smoking status showed
statistically significant associations with increased cancer risk
for all cancer sites combined.

Discussion
Under the restricted criterion, we found statistically significant
elevations in SIRs for all cancer sites combined, prostate and
thyroid cancers, and leukemia; SIRs for lung cancer and colorectal cancer were below 1.0. Multivariable survival analysis
showed no exposure dose-response for all cancer sites combined or prostate cancer, although some risk factors such as age
at September 11, 2001, sex, and current smoking were associated with increased cancer risk. These analyses are most comparable in methodology with the previous restricted only
analysis of Solan et al. (4), which had 5 fewer observation years,
a smaller sample size, and wherein, an elevated SIR was
reported for thyroid cancer only.
Solan et al. found elevations under the unrestricted criterion
for all-sites cancer and prostate, thyroid, and hematologic malignancies and an elevation in soft tissue cancer, no longer evident in the current study. The current study found elevations
under the unrestricted criterion in those same sites and many
others (Supplementary Table 1, available online). Increased selfselection by a sicker subset of the overall responder population,
due to both cancer becoming eligible for federally funded treatment and publicity from previous research on cancer risk
among WTC-exposed populations, could explain these
increases.
Although other studies have revealed elevated SIRs for other
hematologic malignancies, this is the first reported statistically
significant elevated SIR for leukemia (3,4,6,7). Leukemia is
known to occur after exposure to occupational carcinogens,

Factors
Sex†
Male
Female
Age on 9/11/01,† y
Per year
Occupation†
Construction
Protective services
CM&IRG
All other
Smoking†
Current smoker
Former smoker
Never smoked
SSN†,‡
SSN sent to registry
No SSN sent
Derived exposure level§
Low
Medium
High
Very high
Dust exposure/arrival time†
Direct
Significant
Some
No exposure/arrival
9/11–9/14
No exposure/arrival after
9/14
Duration on site†
1st quartile
2nd quartile
3rd quartile
4th quartile
Worked on pile†
Yes
No

All cancer sites
combined
HR (95% CI)

1.21 (0.97 to 1.52)
1.0 (Referent)

Prostate
HR (95% CI)

—
—

1.09 (1.08 to 1.10)

1.13 (1.12 to 1.14)

1.12 (0.92 to 1.36)
1.03 (0.84 to 1.26)
0.96 (0.74 to 1.24)
1.00 (Referent)

1.22 (0.90 to 1.66)
1.09 (0.77 to 1.56)
1.15 (0.76 to 1.74)
1.00 (Referent)

1.29 (1.07 to 1.57)
1.00 (0.85 to 1.17)
1.00 (Referent)

0.74 (0.50 to 1.10)
0.94 (0.73 to 1.21)
1.00 (Referent)

0.95 (0.81 to 1.11)
1.00 (Referent)

1.08 (0.84 to 1.40)
1.00 (Referent)

1.00 (Referent)
0.91 (0.75 to 1.11)
0.99 (0.78 to 1.26)
0.67 (0.40 to 1.12)

1.00 (Referent)
0.82 (0.60 to 1.12)
0.93 (0.64 to 1.36)
0.48 (0.17 to 1.33)

1.07 (0.86 to 1.33)
1.16 (0.93 to 1.46)
0.86 (0.62 to 1.20)
1.06 (0.88 to 1.29)

1.18 (0.82 to 1.69)
1.43 (0.99 to 2.06)
0.93 (0.52 to 1.66)
1.11 (0.80 to 1.54)

1.00 (Referent)

1.00 (Referent)

1.00 (Referent)
1.08 (0.88 to 1.32)
0.99 (0.80 to 1.21)
1.04 (0.85 to 1.26)

1.00 (Referent)
1.13 (0.82 to 1.55)
0.83 (0.59 to 1.16)
0.82 (0.60 to 1.14)

1.02 (0.88 to 1.19)
1.00 (Referent)

0.95 (0.74 to 1.22)
1.00 (Referent)

*CI ¼ confidence interval; CM&IRG ¼ buildings and grounds cleaning and maintenance and electrical, telecommunications, and other installation and repair
groups; HR ¼ hazard ratio; SSN ¼ social security number.
†HRs from a model that included age on 9/11/01, sex, race and/or ethnicity,
clinic, smoking, SSN status, year of registration, occupation, work on pile, duration on site, and dust exposure/arrival time.
‡SSN information sent to registry and used in probabilistic matching included
both full SSN and last four digits.
§HRs from a model that included age, sex, race and/or ethnicity, clinic, smoking,
SSN status, year of registration, occupation, and derived exposure level.

including benzene [burning jet fuel and other sources at the
WTC site (12)], possibly at low levels of exposure (13,14) and
with a latency of several years from exposure (15). Our study did
not find an increase in multiple myeloma, as suggested by other
studies (16,17), although all results are based on a small number
of cases; thus, variation among studies is not surprising.
Although we did not find an increase in multiple myeloma, continued surveillance is warranted, as a study of FDNY firefighters
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found a statistically significant association between WTC exposure and the myeloma precursor monoclonal gammopathy of
undetermined significance (18).
Lung cancer is commonly associated with occupational
exposures, and WTC debris contained substances known to increase lung cancer risk (asbestos, particulate matter), yet we
found the SIR of this cancer to be below 1.00, albeit of borderline
statistical significance (SIR ¼ 0.83, 95% CI ¼ 0.66 to 1.04). Three
considerations for this finding are as follows: Our cohort has a
lower prevalence of smokers compared with the general population; many members are certified with WTC-related musculoskeletal conditions, commonly treated with nonsteroidal, antiinflammatory drugs for pain management that have been
shown to decrease lung cancer risk (19); and latency might be a
greater factor for lung cancer than for other cancers. These
questions should be examined in future studies.
Routine screening for thyroid cancer is not offered through
the WTC Health Program; however, General Responder Cohort
members are routinely administered chest x-rays, and those
with certain respiratory problems are administered chest computerized tomography scans, which can lead to early diagnosis
of thyroid cancer. Consequently, medical surveillance could
partially explain elevations in the thyroid cancer SIR.
An increase in prostate cancer among WTC-exposed firefighters has been reported, although surveillance bias may play
a role, given that prostate-specific antigen screenings are routinely performed as part of the FDNY monitoring program (7)
(the WTC Health Program does not screen for prostate cancer).
Typical latency for prostate cancer has been estimated as long
as 20 years post exposure (20); however, recent research suggests that respiratory exposure to WTC dust could induce inflammatory and immune responses in prostate tissue and that
WTC-related prostate cancer displays a distinct gene expression
pattern that could have resulted from exposure to specific carcinogens (21). These factors could be associated with a shorter latency period for WTC exposure.
Cancers commonly treated in outpatient settings may be
underreported to registries, particularly melanoma and myeloid
leukemia (22,23). Consequently, underreporting of cancer is a
possible source of incomplete case ascertainment in our cohort.
However, such undercounting would also affect the population
rates used in SIR calculations and presumably would be nondifferential with respect to the exposure variables used in our multivariable analyses, leading to loss of power but not bias. Another
potential source of undercounting would be missing SSN information in 68.2% of our cohort, because SSN is an important part
of the probabilistic matching algorithms employed by the registries. Because of a renewed effort to collect the last four digits of
SSN, this current study was able to provide the registries with
partial SSN numbers on an additional 4331 responders, improving
match accuracy and reducing potential undercounting. Based on
a comparison of the registry linkage results on 5627 members initially without SSN with their updated results with the inclusion
of the last four digits of SSN (4331 members) or the full SSN (1296
members), we can estimate registry matching without SSN
results in an undercounting of true cancer numbers by 7.9% compared to full SSN and 5.4% cf last four digits.
Although Solan et al. (4) reported a non-statistically significant suggestion of an exposure dose-response, our analysis
found no exposure effect, regardless of whether component or
derived measures were examined. A more recent FDNY study
(7) compared cancer incidence in their cohort to firefighters
from other cities. Although our analysis used internal
WTC-exposure comparisons whereas the firefighter study used

an external control group, the firefighter study likewise reported
no WTC exposure effect.
Days and hours on-site, location, and dust cloud exposure
have been assumed surrogates for duration and intensity of exposure to cancer-causing substances. However, it is possible
that these categories do not completely capture the true level of
exposures to carcinogens. Similarly, use of respirators and protective clothing may mitigate the effects of exposure.
Unfortunately, however, this information was not consistently
captured via the exposure assessment instrument. Recall bias
may also play a role among those who enrolled up to a decade
or more after exposure, although the percentage of late enrollees remains small (14.2% after 2009). These potential limitations
may result in exposure misclassification, reducing our ability to
identify a dose-response effect, if one exists.
In conclusion, our investigation identified elevated incidence rates in all-sites cancer combined, as well as in prostate,
thyroid, and leukemia when compared to the general population. However, no dose-response association was observed between cancer risk and estimated level of exposure while
working on the WTC rescue and recovery effort. Shorter latency
prostate cancer elevations could be contributed to the unique
makeup of the WTC dust exposure. Future studies of other
WTC-exposed cohorts may similarly find elevations in leukemia. Thyroid cancer continues to show the greatest elevations
in SIR, possibly because of surveillance bias from increased
monitoring and treatment, although thyroid cancer screening is
not offered through the WTC Health Program. Because of the long
latency period of many types of cancer, it is possible that increased rates of other cancers, as well as WTC exposure-cancer
associations, may emerge after longer periods of follow-up.
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